Drug Profile
Bisoctrizole/titanium dioxide
Alternative Names: Bisoctrizole/titanium dioxide pigmentary/titanium dioxide microfine; RV3131A-MV1166; Titanium dioxide/bisoctrizole; V-0096-CRLatest Information Update: 22 May 2014
Price :
$50
*
At a glance
- Originator Orfagen
- Class Peroxides; Phenols; Sunscreens; Triazoles
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 22 May 2014 Discontinued - Phase-II for Skin disorders in United Kingdom (Topical)
- 22 May 2014 Discontinued - Phase-II for Skin disorders in USA (Topical)
- 23 Jul 2013 Bisoctrizole/titanium dioxide withdrawn from Community Register of Orphan Medicinal Products in EU on request of Orfagen